AUTHOR=Fatehi Farzad , Ashrafi Mahmoud Reza , Babaee Marzieh , Ansari Behnaz , Beiraghi Toosi Mehran , Boostani Reza , Eshraghi Peyman , Fakharian Atefeh , Hadipour Zahra , Haghi Ashtiani Bahram , Moravej Hossein , Nilipour Yalda , Sarraf Payam , Sayadpour Zanjani Keyhan , Nafissi Shahriar
TITLE=Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus
JOURNAL=Frontiers in Neurology
VOLUME=12
YEAR=2021
URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.739931
DOI=10.3389/fneur.2021.739931
ISSN=1664-2295
ABSTRACT=Background: Pompe disease, also denoted as acid maltase or acid α-glucosidase deficiency or glycogen storage disease type II, is a rare, autosomal recessive lysosomal storage disorder. Several reports have previously described Pompe disease in Iran and considering increased awareness of related subspecialties and physicians, the disease's diagnosis is growing.
Objective: This guideline's main objective was to develop a national guideline for Pompe disease based on national and international evidence adapting with national necessities.
Methods: A group of expert clinicians with particular interests and experience in diagnosing and managing Pompe disease participated in developing this guideline. This group included adult neurologists, pediatric neurologists, pulmonologists, endocrinologists, cardiologists, pathologists, and physiatrists. After developing search terms, four authors performed an extensive literature review, including Embase, PubMed, and Google Scholar, from 1932 to current publications before the main meeting. Before the main consensus session, each panel member prepared an initial draft according to pertinent data in diagnosis and management and was presented in the panel discussion. Primary algorithms for the diagnosis and management of patients were prepared in the panel discussion. The prepared consensus was finalized after agreement and concordance between the panel members.
Conclusion: Herein, we attempted to develop a consensus based on Iran's local requirements. The authors hope that disseminating these consensuses will help healthcare professionals in Iran achieve the diagnosis, suitable treatment, and better follow-up of patients with infantile-onset Pompe disease and late-onset Pompe disease.